A phase 3 trial of cytisine for the treatment of smoking cessation.

Trial Profile

A phase 3 trial of cytisine for the treatment of smoking cessation.

Planning
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Cytisine (Primary)
  • Indications Smoking withdrawal
  • Focus Registrational; Therapeutic Use
  • Sponsors Achieve Life Sciences
  • Most Recent Events

    • 09 Nov 2017 According to an Achieve Life Sciences media release, the study is expected to initiate in mid-2018.
    • 30 Oct 2017 According to an Achieve Life Sciences media release, phase 3 plans will be presented at VirtualInvestorConferences.com on November 2, 2017.
    • 16 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top